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Abstract
Yaws and trachoma are targeted for eradication and elimination as public health problems. In
trachoma-endemic populations mass administration of azithromycin can simultaneously treat
yaws. We conducted a population-based prevalence survey in the five northernmost prov-
inces of Vanuatu, where trachoma and yaws are suspected to be co-endemic. Clinical signs
of trachoma were evaluated using the WHO simplified grading system, and skin examination
with a serological rapid diagnostic test used to identify yaws. We enrolled 1004 households in
59 villages over 16 islands, and examined 3650 individuals of all ages for trachoma. The overall
adjusted prevalence of trachomatous inflammation-follicular (TF) in 1–9 year-olds was 12.0%
(95% Confidence Interval: 8.1–16.7%), and the overall adjusted prevalence of TT in those
aged 15 years and greater was 0.04% (95% CI 0–0.14%). In multivariate analysis, the odds of
children having TF was 2.6 (95% CI = 1.5–4.4) times higher in households with unimproved
latrines, and independently associated with the number of children in the household (OR 1.3,
95% CI = 1.0–1.6 for each additional child). We examined the skin of 821 children aged 5–14
years. Two children had yaws, giving an estimated prevalence of active yaws in those aged
5–14 years of 0.2% (95% CI = 0.03–0.9%). Mass treatment with azithromycin is recommended
in these provinces. Given the apparent low burden of yaws, integration of yaws and trachoma
control programmes is likely to be useful and cost-effective to national programmes.
Author Summary
Yaws and trachoma are infectious diseases targeted by the World Health Organization
(WHO) for eradication and elimination as a public health problem, respectively. Both
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diseases are found in the rural, isolated and underserved communities of the world’s poor-
est countries. The WHO strategy for trachoma elimination includes Mass Drug Adminis-
tration (MDA) of the antibiotic azithromycin, with population-based prevalence surveys
required to determine where interventions are needed. As yaws can also be treated with azi-
thromycin, in co-endemic areas, azithromycin MDA will likely treat both infections. We
conducted an integrated trachoma and yaws prevalence survey in establish the prevalence
of both diseases in the 5 northern-most provinces of Vanuatu. The estimated prevalence of
trachomatous inflammation—follicular (TF, a sign of C. trachomatis infection) in children
aged 1–9 years was 12.0%, and the estimated prevalence of trachomatous trichiasis (TT,
advanced, potentially blinding disease) in adults aged 15 years and above was 0.04%. Two
children had yaws, giving an estimated prevalence of active yaws in those aged 5–14 years
of 0.2%. Mass treatment with azithromycin is recommended in these provinces. Given the
apparent low burden of yaws, integration of yaws and trachoma control programmes is
likely to be useful and cost-effective to national programmes.
Introduction
The World Health Assembly has targeted yaws and trachoma for global eradication and elimi-
nation-as-a-public-health-problem, respectively, by the year 2020[1]. Both are neglected tropical
diseases found in rural areas of the world’s poorest countries. Trachoma is the world’s most
common infectious cause of blindness, with an estimated 232 million people at risk of irrevers-
ible blindness in 51 countries[2]. Yaws is an infectious disease that causes disfiguring and often
painful lesions of the skin and bones. Although data are limited, it is thought to be endemic in
at least 13 countries, including three in the Pacific[3].
Trachoma is caused by ocular infection with the bacterium Chlamydia trachomatis. Infec-
tion is spread by direct or indirect contact[4][5], and is linked to poor sanitation, crowded liv-
ing conditions and inadequate access to water[6]. Infection in children is self-limiting and
may present with lymphoid follicles on the upper tarsal conjunctivae, known as trachomatous
inflammation-follicular (TF), and/or intense inflammatory thickening of the conjunctivae,
known as trachomatous inflammation-intense (TI). Recurrent infection can lead to scarring of
the tarsal conjunctivae and changes in the morphology of the eyelid, leading to trachomatous
trichiasis (TT), where the eyelashes turn inwards and rub on the globe. Over time, abrasion of
the cornea by eyelashes can lead to an irreversible opacification of the normally clear cornea
that may impair vision and eventually lead to blindness [7][8].
Yaws is caused by infection with the bacterium Treponema pallidum subsp. pertenue. It is
transmitted from person to person through direct skin contact. It presents with papillomas or
normally painless ulcers which, if left untreated, may be followed by multiple skin lesions and
sometimes more severe tissue and bone disease. The majority of clinical cases are seen in chil-
dren under 15 years old (peak incidence 2–10 years), predominantly in isolated rural areas
that have warm and humid climates [9].
The latest WHO clinical guidelines recommend that a confirmed case of yaws should lead
to treatment of the entire community[10]. Implementation of these are challenging if health
workers do not have a means to confirm suspected yaws cases. Traditional syphilis serology
combines a highly specific treponemal antibody test (TPPA/TPHA) with a less-specific non-
treponemal antibody test (VDRL/RPR). The former test remains positive for life, whilst the lat-
ter varies over time, more accurately reflecting current disease activity. A reliable rapid diag-
nostic test (RDT) (DPP-Syphilis Screen and Confirm Chembio, USA) [11][12] has been
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developed with a sensitivity and specificity for treponemal antibodies of 88% and 95% respec-
tively and for non-treponemal antibodies of 88% and 93% respectively.
Mass treatment with azithromycin forms part of the WHO strategies for the elimination of
trachoma and the eradication of yaws. In co-endemic regions, MDA with azithromycin reduces
the community prevalence of both infections[13,14], and therefore the integration of surveys
for the two diseases is a logical step to provide baseline data for treatment planning.
Vanuatu is a country comprising approximately 80 islands, situated approximately 1800km
North-East of Australia (Fig 1 (Panel A)). It has a total population of over 230,000 people and
is composed of 6 provinces: Torba, Sanma, Penama, Malampa, Shefa and Tafea (Fig 1 (Panel
B)) [15].
In 2009, a trachoma rapid assessment was conducted in 17 sites in Tafea and Shefa prov-
ince, indicating that trachoma was a likely to be significant public health burden [16]. A popu-
lation-based prevalence survey was therefore required to determine the prevalence of TF in
Vanuatu, to guide application of community-level interventions[17].
In 2011 and 2012, the Vanuatu government reported 2,197 and 2,154 cases of yaws, respec-
tively[18], with the highest reported numbers of cases occurring in the Provinces of Tafea and
Sanma. In 2013, as part of the national yaws control programme, the government carried out
mass drug administration (MDA) of azithromycin in Tafea province.
We carried out a cross-sectional prevalence survey in order to estimate the baseline preva-
lence of trachoma and yaws in the 5 northern-most provinces of Vanuatu. The objectives were
to estimate the prevalence of TF in children aged 1–9 years, the prevalence of TT in adults
aged 15 years and greater, and the prevalence of yaws skin lesions in children aged 5–14 years.
Due to the recent MDA with azithromycin, Tafea province was excluded from these surveys.
Methods
A two-stage cluster-randomised survey was conducted between 20th October to the 21st Novem-
ber 2014, and followed the standard methodological principles of the Global Trachoma Mapping
Project (GTMP)[19]. Excluding Tafea Province, the provinces of Vanuatu surveyed have a total
estimated rural population of 144,276[20] and were therefore considered as one Evaluation Unit
(EU), in accordance with WHO guidelines for trachoma prevalence surveys [21]. Based on the
anticipated number of children per household from the latest census data, 42 clusters were selected
for survey. The islands were stratified in the sampling to ensure representation from each island
group. Clusters were selected from island groups using probability proportional to size methodol-
ogy. In each selected cluster, 30 households were selected randomly by drawing lots from a list of
names of household heads compiled at the time of survey. If selected clusters contained fewer
than 30 households, all households were invited to participate, and a number of randomly selected
households from the next-nearest village sufficient to bring the total to 30 were randomly selected
using the same methods.
After obtaining informed consent, all individuals over the age of one year from selected
households were examined for clinical signs of trachoma using the WHO simplified grading
system[8][19]. Additionally, in those aged 5–14 years, graders performed an examination of the
skin of the whole body, excluding the genitals and buttocks. Prior to the survey, graders were
trained to perform a dermatology exam to recognise skin lesions consistent with active yaws, as
classified in the WHO yaws pictorial guide [22]. In children with skin lesions consistent with
active yaws, a finger-prick blood sample was collected and an RDT for yaws was performed.
The RDT was considered positive if both the treponemal and non-treponemal component were
positive in accordance with manufacturer’s instructions.
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Household Risk factors Survey
Data collectors were trained to collect Water, Sanitation and Hygiene (WASH) variables at
household level[19]. Data were obtained by interviewing the head of the household or respon-
sible adult. The questionnaire included items on access to and use of latrines, access to and use
of water sources for drinking and washing, and the estimated time needed to retrieve water.
The questionnaire was supported through use of observational data obtained by the data col-
lectors on latrine type, handwashing facilities near to the latrine and the presence of soap and
water at the handwashing facility at the time of survey.
Statistical Analysis
Statistical analysis for risk factors was carried out using Stata 10.2 (Stata Corp, TX,USA). Con-
fidence intervals around prevalence estimates were constructed by bootstrapping the adjusted
cluster proportions for TF and yaws in R 3.0.2 (The R Foundation for Statistical Computing,
2013). An exact binomial confidence interval was used to derive a TT upper confidence inter-
val. Risk factor analysis was restricted to the binary outcome of the presence of TF in 1–9 year
old children. Where present, TF is maximally found in this age-group, and control interven-
tions are tiered by the prevalence in this age range. A mixed effects logistic regression model
was used to evaluate the effect of each explanatory variable. Odds ratios were adjusted by
household and cluster. Univariable associations were included in the multivariable model if
p0.05. Mantel-Haenszel Chi-square tests were used to assess collinearity between indepen-
dent variables, with variables considered for exclusion if significant collinearity was demon-
strated (p0.05). A multivariable model was developed using a step-wise inclusion approach,
with the decision to retain a variable based on a likelihood ratio test between the included/
excluded models using a significance level of p = 0.05. Age and sex were included in the model
a priori.
Ethical Considerations
The overall study protocol was approved by the Executive Committee of the Ministry of Health
of Vanuatu, and the ethics committee at the London School of Hygiene & Tropical Medicine.
Both ethics committees considered the project to be a low-risk activity considered to be part of
routine public health services, and therefore approved the use of verbal consent throughout
the project.
All adult subjects provided informed consent before examination. For all those examined
under 18 years of age, consent was provided by their parent or guardian on their behalf. Con-
sent was recorded electronically on a custom-made smartphone application used for all data
collection.
All individuals found to have TF or TI were offered treatment with oral azithromycin or
topical tetracycline. All individuals found to have signs of TT were referred for further assess-
ment at the nearest eyecare centre. All individuals found to have clinical evidence of active
yaws were offered treatment with azithromycin. In addition, all villages where cases of yaws
were found were offered total community treatment with azithromycin. All data were anon-
ymised after collection for the purposes of analysis.
Fig 1. (Panel A) General location map for Vanuatu. (Panel B) Provinces and villages over 12 islands included in the survey,
Global Trachoma Mapping Project, Vanuatu, 2014. Shapefile credit: Global Administrative Areas (gadm.org); Basemap
credit: Esri, Openstreetmap.
doi:10.1371/journal.pntd.0005267.g001
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Results
A total of 59 villages were surveyed over 16 islands. We invited 1004 households and 4095 indi-
viduals to participate, resulting 3650 (89.1%) individuals consenting to examination (S1
Table). 1869 (51.2%) of those examined were female. 240 (5.8%) household members were
absent at the time of survey and 205 (5.0%) did not give consent to examination.
135(14.5%) of 928 children aged 1–9 years had TF, with an age-adjusted TF prevalence of
12.0% (95%CI 8.1–16.7) Only two cases of TT were identified out of 2511 adults aged 15 years
and greater. This represents an age- and sex-adjusted TT prevalence in adults of 0.04% (95%CI
0.0–0.14%; unadjusted prevalence in adults 0.08%). 3 additional TT cases were identified in
children aged 5, 6 and 14 years, which, after referral for ophthalmology opinion, were found to
be false positives. The adjusted prevalence of TT in the whole population was 0.02% (95%CI
0–0.1%; unadjusted prevalence 0.04%)
Clinical Yaws
1000 children aged 5–14 years were sampled for inclusion in the study. 821 (82.1%) consented
to examination. Twenty-two (2.7%) had clinical signs consistent with yaws. Six children (0.7%)
had skin lesions consistent with yaws–three had papillomata, two had ulcers, one had squamous
macules. A total of 18 children (2.2%) had objective bony swelling on examination, with 16 hav-
ing no associated skin lesions. Two children (0.2%) met the criteria for clinically active yaws,
having skin lesions consistent with yaws and objective bony swelling.
Treponemal RDT Results
Five children with skin lesions consistent with yaws and had a subsequent RDT. Only 2 out of
5 children had a positive RDT. Of the two children with both skin lesions and bony swelling
one had a positive RDT. Three children were reported to have had treatment for yaws with
benzathine penicillin in the preceding 12 months. The estimated population-level prevalence
of active yaws in 5–14 years was 0.2% (95%CI 0.03–0.9%).
Risk Factors Associated with TF
Univariable analyses of associations of TF are shown in S2 Table. All children included in the
study had access to a shared or private latrine. The final multivariable model (S3 Table) showed
that TF was strongly and independently associated with a household’s use of an unimproved pit
latrine (OR 2.6 (95%CI 1.5–4.4)), the number of children in the household (OR 1.3 –linear
increase with each additional child (95%CI 1.0–1.6)), and a child’s age (OR 1.1 –linear increase
with each additional year (95%CI 1.0–1.2)).
Discussion
Trachoma is endemic in Vanuatu. The prevalence of TF in children aged 1–9 years exceeds the
threshold above which the WHO recommends MDA with azithromycin as well as facial cleanli-
ness and environmental improvement initiatives. The age and sex standardised TT prevalence
showed that TT was not a significant public health problem, and was below the WHO elimina-
tion threshold of 0.2% of the population aged 15 years and greater[23].
Consistent with other studies, we found that the number of children living in the household
aged 1–9 years was strongly associated with TF[24,25], the odds increasing with each addi-
tional child. Trachoma is thought to be spread through close contact, via exposure to infected
ocular or nasal secretions. The reservoir of infection is predominantly in children[26–28], and
so it stands to reason that the more close contact opportunities children have with other
Trachoma and Yaws in Vanuatu
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potentially-infected children, the higher the chance that they will become infected themselves.
This association was not maintained when considering the number of inhabitants of the
household overall, consistent with contact with infected children preferentially facilitating
spread.
All households reported having access to some form of latrine and open air defaecation was
not reportedly common. The WHO/UNICEF Joint Monitoring Programme (JMP) for Water
Supply and Sanitation defines an unimproved form of sanitation to be that which fails to sepa-
rate faecal material from human contact[29]. We found unimproved sanitation facilities in 385
households in which children aged 1–9 years were resident. After accounting for other possible
confounders, children living in such households were 2.6 times more likely to have signs of TF
in the survey.
Trachoma has previously been associated with poor sanitation [6,30,31]. This is thought to
be because areas of open defecation provide a preferential breeding ground for eye-seeking
Musca sorbens flies which can mechanically transmit C. trachomatis between individuals as a
passive vector. M. sorbens preferentially breeds on human faeces left lying on the soil, with fae-
ces in pit latrines of any kind, including “unimproved” latrines, not constituting a site for ovi-
position [32,33]. In our data, poor latrine access may simply be a surrogate for deprivation
overall, with its associated limitations in economic and educational opportunities. It was not
possible to control for these variables in our analyses.
In addition, any sanitation that is shared between households is considered to be unim-
proved. This is based on the belief that in shared facilities there are few incentives for indi-
vidual users to keep the facility clean, and more vulnerable groups, including women and
children, are less likely to use them[34,35]. In our survey the association between TF and
the use of an unimproved latrine was not maintained in multivariable analyses if shared
latrines alone were considered as a risk factor, suggesting that the latrine type available,
rather than communal use conferred increased risk.
We found an increasing odds of TF with increasing age in the range 1–9 years. Most studies
report a higher prevalence and odds of TF in younger children[27,36]. Superficially this may
be at odds with suggestions that young children are the main reservoir of infection in this pop-
ulation, although we are careful here to acknowledge the difference between ocular C. tracho-
matis infection and the clinical signs of active trachoma. In highly endemic areas, infection is
likely to be first acquired in early infancy, with the age-of-first-acquisition on average increas-
ing with decreasing prevalence. These differences in the age associations of infection and active
trachoma are thought to be explained by a degree of immunity acquired in childhood, and
socio-behavioural factors linked to hygiene practices and close contacts which may lessen the
inflammatory response to, without changing the risk of, infection. It is possible that non-chla-
mydial bacteria such as Streptococcus pneumonia and Haemophilus influenzae also contribute
to the follicular phenotype in individuals previously sensitised to C. trachomatis [37,38]. The
phenotype seen may also be a response to other C. trachomatis serovars.
Due to the small number of cases of active yaws in this study we did not conduct a risk-fac-
tor analysis for yaws, but poor sanitation and reduced access to hand-washing facilities was
associated with an increased risk of yaws in a previous study in the Pacific [39]. This suggests
that, in addition to MDA, the F&E components of a trachoma elimination programme may
have additional synergistic benefits for yaws control.
Although few in number, this survey identified cases of active yaws in Vanuatu. The aim for
the WHO yaws control programme is eradication, therefore the identification and treatment
of such cases is important. Yaws is seasonal, with higher numbers during the rainy season[40].
Our survey was conducted at the end of the dry season/beginning of the rainy season, and it is
therefore possible that we have underestimated the true burden of disease. Additionally, the
Trachoma and Yaws in Vanuatu
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rapid diagnostic test was not performed on 16 individuals who had bony swellings but no skin
lesions. The finding of bony swellings in isolation is consistent with active yaws, but this clini-
cal sign was considered too non-specific to proceed to RDT in this survey. It was anticipated
that the inclusion of those with this sign alone would lead to a prohibitively large number of
RDTs being required, although in hindsight this would have only required a total of 22 RDTs
(children with either bony swellings or skin lesions or both)—a finding that may guide future
clinical/RDT surveys. Only 40% of children with skin lesions clinically consistent with yaws
had a positive RDT, in keeping with a study conducted in Tafea province in 2013, in which
35.5% of children with clinically suspected yaws had positive serology [41]. These findings sug-
gest that relying only on clinical diagnosis of yaws is insufficient and efforts should be made to
increase access to RDTs. Asymptomatic treponemal infection was not evaluated, so we do not
have an estimate of the prevalence of latent yaws in this population. In survey data from other
countries in the Pacific, there can be between 4–10 latent cases of yaws per active case found
[3,39,42]. The routine clinical case notification rate (which does not require serological confir-
mation) from the five provinces included in this study is approximately 0.2 cases per 100 peo-
ple, which is consistent with the results found in our survey (personal communication-
Fasihah Taleo)
Based on these findings, mass treatment with azithromycin and implementation of the F&E
components of the SAFE strategy (with the provision of improved latrines where needed) are
recommended in northern Vanuatu to eliminate trachoma and eradicate yaws as public health
problems. Given the apparent low burden of yaws, integration of the two control programmes
is likely to be useful and cost-effective to national programmes.
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